ArticleHaematologica2018
BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib.
Konstantin Byrgazov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ArticleHaematologica2018
Konstantin Byrgazov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.